25/11/2025
Just in: A major new study (Nature Communications, Nov 2025) confirms what we’ve been seeing in patients for years.
Chronic low-grade inflammation doesn’t just cause discomfort—it permanently remodels the bone marrow, replacing healthy supportive cells with pro-inflammatory ones.
This creates a self-perpetuating loop that drives clonal hematopoiesis (CHIP) and dramatically raises risk:
◉ 10× blood cancer
◉ 2× cardiovascular disease
◉ Faster progression to MDS/leukemia
◉ Increased mortality
55+? This process (called “inflammaging”) is likely already at work.
The science backed solution: culture-expanded mesenchymal stem cells (MSCs) powerfully reduce systemic inflammation by lowering TNF-α, IL-6, IFN-γ, shifting macrophages to anti-inflammatory mode, and breaking the cycle.
At DVC Stem, our IRB-approved protocol uses the highest-potency umbilical cord-derived MSCs specifically chosen for their immunomodulatory strength.
Patients consistently report lower inflammatory markers, reduced pain, and renewed energy.Ready to address inflammation at its source?
Learn more about our therapy → www.dvcstem.com/protocol